F
Fractyl Health, Inc. (GUTS)
NGM – Real Time Price. Currency in USD
0.45
-0.02 (-5.20%)
At close: Mar 27, 2026, 4:00 PM EDT
0.46
+0.01 (2.54%)
After-hours: Mar 27, 2026, 7:52 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
0.45
-0.02 (-5.20%)
At close: Mar 27, 2026, 4:00 PM EDT
0.46
+0.01 (2.54%)
After-hours: Mar 27, 2026, 7:52 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.27 | 6.05 | 10 | |
| Quick ratio | 4.27 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.54 | 1.04 | 4.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 120K | 93K | 3K |
| Gross Profit | -676K | -452K | -243K | -634K | -1M |
| Operating Income | -37M | -49M | -51M | -94M | -99M |
| Net Income | -39M | -46M | -77M | -69M | -122M |
| EBITDA | -36M | -49M | -51M | -93M | -98M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | 65.38 | 5.5 |
| Next quarter | N/A | 67.02 | 5.5 |
| Current year | -100 | 0.74 | 1.5 |
| Next year | N/A | 57.09 | 5.5 |
| Weighted average score | 4.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -63.51 | -25.65 | -6.68 | 3.3 |
| Y/Y | -99.99 | -96.78 | -65.11 | -24.48 | 1.0 |
| 3y average | 658.5 | -24.98 | N/A | -29.06 | 3.3 |
| 5y average | 794.7 | -20.32 | N/A | -21.33 | 3.3 |
| Weighted average score | 2.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $77.7M significantly exceed its total debt $62.2M, ensuring strong financial flexibility
Total current assets $79.7M exceed Total current liabilities $18.7M, highlighting excellent liquidity
Debt-to-equity ratio (-19.6) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$22.7M limits the company's ability to reinvest or pay down debt